Quantcast

Latest Liver biopsy Stories

2010-01-27 10:55:36

NAFLD and NASH patients at greater risk of death than the general population Researchers from the Karolinska Institute determined that patients with nonalcoholic fatty liver disease (NAFLD) have a higher overall mortality rate compared with the general population. Details of this study are available in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. While NAFLD is the most common cause of elevated...

2010-01-27 10:51:34

Sonic detection of liver stiffness emerges as a useful screening and prognostic test Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by...

2009-07-29 10:18:08

A major clinical challenge is to find the best method to evaluate and to manage the increasing numbers of patients with chronic liver disease. Liver biopsy, due to its risks and limitations, is no longer considered mandatory as the first-line indicator of liver injury, and several markers have been developed as non-invasive alternatives.The assessment of liver fibrosis by non-invasive techniques, such as biomarkers ºFibroTest®...

2009-06-08 08:26:00

MADISON, N.J., June 8 /PRNewswire-FirstCall/ -- A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients. The Hepascore test panel is provided...

2009-01-01 08:30:22

Liver biopsy is still considered the gold standard for grading, staging and "stad-ging" the chronic liver disease. In addition, it remains a primary source for acquiring new knowledge on the liver pathology. Demand for precise evaluations of the fibrosis and inflammatory tissue detectable in liver biopsy samples has been fuelled by the need to understand the closest-to-real effects of new antiviral molecules on the lesions characterizing the histological patterns of chronic viral, toxic,...

2008-11-04 00:00:05

Imaging technology can identify liver fibrosis with high accuracy, limiting the need for biopsies to diagnose diseases, U.S. researchers say. Dr. Jayant Talwalkar, a hepatologist at the Mayo Clinic in Rochester, Minn., said magnetic resonance elastography, or MRE, produces color-coded images known as elastograms that indicate how internal organs, muscles and tissues would feel to the touch. Other imaging methods are unable to provide that information. "Knowing the liver's elasticity or...

2008-11-02 12:00:04

Bristol-Myers Squibb Company (NYSE:BMY) today announced data from two separate cohort evaluations, in which long-term treatment with BARACLUDE(R) (entecavir) was associated with improved liver histology, including improvement in fibrosis, in chronic hepatitis B patients. The histology data were presented today at the 59th Annual Meeting of the American Association for the Study of Liver Diseases. New long-term histology results were presented from a cohort of 57 nucleoside-naive patients...

2008-09-02 15:00:06

A Chinese-led study has found non-invasive transient elastography can measure liver stiffness, accurately diagnosing patients with late-stage liver disease. The researchers, led by Dr. Henry Chan of the Prince of Wales Hospital in Hong Kong, said liver biopsy has long been the gold standard for assessing liver disease. However, it is limited by invasiveness, risk of complications, patient discomfort and the availability of expertise. On the other hand, the researchers said liver stiffness...

2008-08-19 06:00:57

Research and Markets (http://www.researchandmarkets.com/research/ff05c9/noninvasive_approa) has announced the addition of Decision Resources, Inc.'s new report "Noninvasive Approaches Offer Substantial Market Potential in Liver Disease Diagnostics" to their offering. Novel noninvasive liver diagnostics are poised to revolutionize the diagnosis of liver disease and increase drug-treatment rates in this indication. In this report, we discuss current liver disease diagnostic techniques and...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.